Viking Therapeutics, Inc. (NASDAQ:VKTX) Triggers Near-Term Volatility As Trial Safety Signals Emerge
![]() |
Viking Therapeutics enters a period of heightened volatility after recent clinical updates; balance-sheet strength contrasts with negative operating results and mixed technical signals that point to a contested short-term price path. |









